Cell BiologybioRxivPreprint
Lonafarnib Partially Reverses Cardiac Senescence in Human and Mouse Progeria Models via Autophagy Activation
Luís Miguel Monteiro, Patrícia R. Pitrez, Simão Correia-Santos…·Lino Ferreira
This study identifies lonafarnib as a potential therapy for progeria-related cardiac senescence by activating autophagy and reducing progerin expression in human and mouse models.